When TNBC was further subdivided into basal-like BC (BLBC) and unclassified subgroups, SOX10 expression was higher in the BLBC subgroup (in primary tumors: 42.2% vs 23% and in nodal metastasis: 42.3% vs 27.3%) [14]. This evidence concerns the gene SOX10 and breast cancer.